NM_005591.3(MRE11):c.771A>G (p.Glu257=) AND Ataxia-telangiectasia-like disorder 1

Clinical significance:Benign/Likely benign (Last evaluated: Dec 13, 2019)

Review status:2 stars out of maximum of 4 stars

criteria provided, multiple submitters, no conflicts

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV001112690.2

Allele description [Variation Report for NM_005591.3(MRE11):c.771A>G (p.Glu257=)]

NM_005591.3(MRE11):c.771A>G (p.Glu257=)

Gene:
MRE11:MRE11 homolog, double strand break repair nuclease [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q21
Genomic location:
Preferred name:
NM_005591.3(MRE11):c.771A>G (p.Glu257=)
Other names:
p.E257E:GAA>GAG
HGVS:
  • NC_000011.10:g.94471648T>C
  • NG_007261.1:g.27227A>G
  • NM_001330347.2:c.771A>G
  • NM_005590.4:c.771A>G
  • NM_005591.3:c.771A>G
  • NP_001317276.1:p.Glu257=
  • NP_005581.2:p.Glu257=
  • NP_005582.1:p.Glu257=
  • LRG_85t1:c.771A>G
  • LRG_85:g.27227A>G
  • LRG_85p1:p.Glu257=
  • NC_000011.9:g.94204814T>C
  • p.E257E
Links:
dbSNP: rs13447632
NCBI 1000 Genomes Browser:
rs13447632
Molecular consequence:
  • NM_001330347.2:c.771A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_005590.4:c.771A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_005591.3:c.771A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Ataxia-telangiectasia-like disorder 1 (ATLD1)
Identifiers:
MONDO: MONDO:0024557; MedGen: C4012790; Orphanet: 251347; OMIM: 604391

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001270378Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Likely benign
(Jan 12, 2018)
germlineclinical testing

Citation Link,

SCV001474090ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratoriescriteria provided, single submitter
Benign
(Dec 13, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Clinical Services Laboratory,Illumina, SCV001270378.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories, SCV001474090.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 6, 2021

Support Center